XML 29 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
Restructuring Activities (Notes)
9 Months Ended
Sep. 30, 2016
Restructuring and Related Activities [Abstract]  
Restructuring and Related Activities Disclosure [Text Block]
Restructuring Activities
Due to economic conditions, including low energy prices and global competition, the Company implemented a number of cost reduction or avoidance actions during 2015 and 2016, including headcount reductions. During the three and nine months ended September 30, 2016, the Company incurred severance and other restructuring charges of $202 and $5,883 associated with headcount reductions in all of its segments. These charges were recorded in cost of sales ($159 and $2,432 for the three and nine months ended September 30, 2016) and selling, general, and administrative expenses ($43 and $3,451 for the three and nine months ended September 30, 2016) in the condensed consolidated statements of operations. The Company is closely monitoring its end markets and order rates and will continue to take appropriate and timely actions as necessary.
During 2015, Chart announced its intention to close certain D&S leased facilities.  These closures were cost reduction measures in response to lower orders within D&S.  Total cost incurred during 2015 related to these closures was $4,810. For the three and nine months ended September 30, 2015, charges incurred related to these closures were $2,800 and $4,100, respectively, and included lease exit costs, long-lived asset impairments, and other miscellaneous costs. These charges were recorded in cost of sales ($400 and $1,700 for the three and nine months ended September 30, 2015) and selling, general and administrative expenses ($2,400 for both the three and nine months ended September 30, 2015) in the condensed consolidated statements of operations. The remaining accrual for the facility restructuring costs within D&S as of September 30, 2016 was $2,380. These costs are expected to be paid out over the terms of the associated leases which are expected to end in 2023.
The following tables summarize the Company’s restructuring activities for the three and nine months ended September 30, 2016:
 
Three Months Ended September 30,
 
Energy & Chemicals
 
Distribution & Storage
 
BioMedical
 
Corporate
 
Total
Balance as of June 30, 2016
$
544

 
$
4,796

 
$
368

 
$
276

 
$
5,984

Restructuring charges
159

 
43

 

 

 
202

Cash payments and other
(267
)
 
(1,085
)
 
(168
)
 
(191
)
 
(1,711
)
Balance as of September 30, 2016
$
436

 
$
3,754

 
$
200

 
$
85

 
$
4,475

 
Nine Months Ended September 30,
 
Energy & Chemicals
 
Distribution & Storage
 
BioMedical
 
Corporate
 
Total
Balance as of January 1, 2016
$
1,106

 
$
3,446

 
$
430

 
$
850

 
$
5,832

Restructuring charges
821

 
3,807

 
521

 
734

 
5,883

Cash payments and other
(1,491
)
 
(3,499
)
 
(751
)
 
(1,499
)
 
(7,240
)
Balance as of September 30, 2016
$
436

 
$
3,754

 
$
200

 
$
85

 
$
4,475